Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Study explores how medical info delivery shapes cancer care decisions

NCT ID NCT06722846

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 39 times

Summary

This study looks at how the way medical information is presented influences treatment choices for people with advanced cancer. About 400 participants will fill out questionnaires and review made-up case scenarios. The goal is to learn how to better communicate health options to empower patients in their care planning.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors communicate better with patients, leading to more informed and personalized cancer care decisions.

What could go wrong

This is an observational study using hypothetical scenarios, not real treatments. The results may not directly translate to real-world patient choices or outcomes.

Conditions

The condition(s) this trial relates to.

aggressive B-cell non-Hodgkin lymphoma cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.